Dataset Information


Identification of two novel anti-fibrotic benzopyran compounds produced by engineered strains derived from Streptomyces xiamenensis M1-94P that originated from deep-sea sediments.

ABSTRACT: The benzopyran compound obtained by cultivating a mangrove-derived strain, Streptomyces xiamenensis strain 318, shows multiple biological effects, including anti-fibrotic and anti-hypertrophic scar properties. To increase the diversity in the structures of the available benzopyrans, by means of biosynthesis, the strain was screened for spontaneous rifampicin resistance (Rif), and a mutated rpsL gene to confer streptomycin resistance (Str), was introduced into the S. xiamenensis strain M1-94P that originated from deep-sea sediments. Two new benzopyran derivatives, named xiamenmycin C (1) and D (2), were isolated from the crude extracts of a selected Str-Rif double mutant (M6) of M1-94P. The structures of 1 and 2 were identified by analyzing extensive spectroscopic data. Compounds 1 and 2 both inhibit the proliferation of human lung fibroblasts (WI26), and 1 exhibits better anti-fibrotic activity than xiamenmycin. Our study presents the novel bioactive compounds isolated from S. xiamenensis mutant strain M6 constructed by ribosome engineering, which could be a useful approach in the discovery of new anti-fibrotic compounds.


PROVIDER: S-EPMC3826148 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4344598 | BioStudies
2014-01-01 | S-EPMC4053376 | BioStudies
1000-01-01 | S-EPMC4705527 | BioStudies
2019-01-01 | S-EPMC6585501 | BioStudies
1000-01-01 | S-EPMC3347021 | BioStudies
| PRJNA667761 | ENA
2019-01-01 | S-EPMC6502367 | BioStudies
2020-01-01 | S-EPMC7249682 | BioStudies
1000-01-01 | S-EPMC2944619 | BioStudies
2015-01-01 | S-EPMC4714850 | BioStudies